Ueshima, E.; Sofue, K.; Komatsu, S.; Ishihara, N.; Komatsu, M.; Umeno, A.; Nishiuchi, K.; Kozuki, R.; Yamaguchi, T.; Matsuura, T.;
et al. Immunoscore Predicted by Dynamic Contrast-Enhanced Computed Tomography Can Be a Non-Invasive Biomarker for Immunotherapy Susceptibility of Hepatocellular Carcinoma. Cancers 2025, 17, 948.
https://doi.org/10.3390/cancers17060948
AMA Style
Ueshima E, Sofue K, Komatsu S, Ishihara N, Komatsu M, Umeno A, Nishiuchi K, Kozuki R, Yamaguchi T, Matsuura T,
et al. Immunoscore Predicted by Dynamic Contrast-Enhanced Computed Tomography Can Be a Non-Invasive Biomarker for Immunotherapy Susceptibility of Hepatocellular Carcinoma. Cancers. 2025; 17(6):948.
https://doi.org/10.3390/cancers17060948
Chicago/Turabian Style
Ueshima, Eisuke, Keitaro Sofue, Shohei Komatsu, Nobuaki Ishihara, Masato Komatsu, Akihiro Umeno, Kentaro Nishiuchi, Ryohei Kozuki, Takeru Yamaguchi, Takanori Matsuura,
and et al. 2025. "Immunoscore Predicted by Dynamic Contrast-Enhanced Computed Tomography Can Be a Non-Invasive Biomarker for Immunotherapy Susceptibility of Hepatocellular Carcinoma" Cancers 17, no. 6: 948.
https://doi.org/10.3390/cancers17060948
APA Style
Ueshima, E., Sofue, K., Komatsu, S., Ishihara, N., Komatsu, M., Umeno, A., Nishiuchi, K., Kozuki, R., Yamaguchi, T., Matsuura, T., Tada, T., & Murakami, T.
(2025). Immunoscore Predicted by Dynamic Contrast-Enhanced Computed Tomography Can Be a Non-Invasive Biomarker for Immunotherapy Susceptibility of Hepatocellular Carcinoma. Cancers, 17(6), 948.
https://doi.org/10.3390/cancers17060948
